1.5 million clinicians.
One living network.

Patterns we observe

• Heart-failure guideline updates drive the deepest read sessions of any cardiology topic.
• Interest in cardiomyopathy phenotyping is climbing steadily across interventional communities.
• Lipid-management content re-engages the same readers in recurring 6-week cycles.

Patterns we observe

• Sepsis protocol content spikes with each major trial readout, then settles into sustained reference use.
• Ventilation-strategy debates generate the longest comment-to-read ratios in the network.
• Cross-reading with nephrology signals growing interest in acute kidney support.

Patterns we observe

• Biologic-switching criteria are the most re-read content class in psoriasis.
• Atopic dermatitis readers show strong appetite for head-to-head efficacy data.
• JAK-inhibitor safety updates trigger immediate, network-wide reading surges.

Patterns we observe

• Incretin-based therapy content dominates engagement, well beyond diabetes specialists.
• Obesity-management pathways are read deeply by primary care, signalling readiness to treat.
• Thyroid-nodule workup content shows stable, reference-style usage patterns.

Patterns we observe

• Bispecific antibody readouts trigger rapid conviction movement in B-cell malignancies.
• Anticoagulation evidence-seeking peaks around bleeding-risk re-evaluations.
• Cytopenia management patterns differ markedly between academic and community settings.

Patterns we observe

• MASH staging and treatment-eligibility content is the fastest-growing read category.
• IBD biologic-sequencing questions dominate long-session reading.
• Hepatocellular screening pathways show strong regional variation in engagement.

Patterns we observe

• Vaccine-hesitancy counselling content engages far beyond ID specialists.
• Antimicrobial-resistance updates drive recurring engagement from hospital prescribers.
• Outbreak-linked reading surges predict local clinical demand within days.

Patterns we observe

• SGLT2 renal-protection evidence keeps pulling cardiology readers into nephrology content.
• Dialysis-timing debates show deep engagement from smaller-centre clinicians.
• IgA nephropathy therapy content is an emerging high-growth signal.

Patterns we observe

• Neuromuscular and polyneuropathy diagnostics drive the longest read times in the network.
• Migraine-prevention content re-engages readers around new mechanism launches.
• Movement-disorder differential content shows classic pre-adoption reading patterns.

Patterns we observe

• ADC sequencing questions dominate engagement across tumour types.
• Biomarker-testing content is read most deeply where access barriers are highest.
• Community oncologists show fast-rising interest in immunotherapy de-escalation.

Patterns we observe

• Anti-VEGF durability data drives concentrated, decision-oriented reading.
• Geographic-atrophy treatment content shows early-adopter engagement patterns.
• Surgical-technique video content earns the highest return-visit rates.

Patterns we observe

• Peri-operative anticoagulation guidance is the top cross-specialty read.
• Cartilage-repair biologics show exploratory reading without conviction yet.
• Outpatient-arthroplasty pathways engage high-volume centres most.

Patterns we observe

• Vaccine-schedule updates generate immediate, near-universal engagement.
• RSV-prevention content shows sustained reading well past launch season.
• Adolescent obesity-treatment eligibility is a rapidly rising query theme.

Patterns we observe

• Biologic eligibility in severe asthma is the most re-read decision content.
• COPD triple-therapy evidence shows steady conviction building across regions.
• ILD referral-timing content engages generalists as much as specialists.

Patterns we observe

• Rapid-acting antidepressant evidence draws intense, short-cycle reading.
• Long-acting injectable content shows steady engagement from community prescribers.
• ADHD diagnostic content in adults is a fast-growing cross-specialty theme.

Patterns we observe

• AI-assisted detection studies drive the highest engagement per article.
• Contrast-safety protocol updates show immediate reference-style adoption.
• Screening-interval debates pull sustained cross-specialty readership.

Patterns we observe

• JAK-versus-biologic positioning is the dominant evidence-seeking theme.
• Early-arthritis referral pathways engage primary care at scale.
• Giant-cell arteritis fast-track content shows strong seasonal patterns.

Patterns we observe

• Advanced prostate-cancer sequencing drives the deepest engagement.
• Overactive-bladder therapy comparisons show stable reference usage.
• Stone-prevention metabolic workup content is quietly gaining depth.

Patterns we observe

• Diagnostic-odyssey content is read longest, signalling the true barrier is recognition.
• Therapy-switch criteria articles reliably precede prescribing movement by 60 to 90 days.
• Cross-specialty reading maps where undiagnosed patients are most likely managed.

Patterns we observe

• Complement-pathway therapeutics show classic emerging-conviction reading.
• Biosimilar-switching evidence engages payers' clinical advisors as much as prescribers.
• IgG4-related disease recognition content is a steady cross-specialty grower.